bluebird bio Reports First Quarter 2015 Financial Results and Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
bluebird bio (BLUE) Misses Q1 EPS by 15c
May 6, 2015 4:14 PM EDTbluebird bio (NASDAQ: BLUE) reported Q1 EPS of ($0.76), $0.15 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $6.2 million.
For earnings history and earnings-related data on bluebird bio (BLUE) click here.
... More